[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01519]



[[Page 2577]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by-the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

------------------------------------------------------------------------
           Company                FR docket             Published
------------------------------------------------------------------------
Noramco Inc.................  83 FR 53107       October 19, 2018.
Catalent CTS, LLC...........  83 FR 54613       October 30, 2018.
United States Pharmacopeial   83 FR 54611       October 30, 2018.
 Convention.
Fisher Clinical Services,     83 FR 54612       October 30, 2018.
 Inc.
Cambrex High Point, Inc.....  83 FR 54610       October 30, 2018.
Sharp (Bethlehem), LLC......  83 FR 54612       October 30, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each company's 
maintenance of effective controls against diversion by inspecting and 
testing each of the company's physical security systems, verifying each 
company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed companies.

    Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01519 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P